parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Patient-Specific iPSC-Derived Astrocytes Contribute to
Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration npj Parkinson's Disease CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research Springer Nature Link Decoding Parkinson's Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations PMC Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports
Pay in 4 interest-free payments of $7.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





